FDA Qualifies Facial PRO As New Medical Device Development Tool
The US agency has qualified the FACE-Q | Aesthetics patient-reported outcome instrument through its MDDT program.
You may also be interested in...
Patient-Reported Outcome (PRO) instruments are the focus of a 26 January final guidance from the US agency. Sponsors can lean on the guidance when selecting, developing or modifying tools for patient data collection.
US Medicare has granted a new technology add-on payment (NTAP) for an innovative technology designed to treat adult spinal deformity.
Agency issued an emergency use authorization to Labcorp for its OTC that detects COVID-19, flu and respiratory syncytial virus.